期刊文献+

Denaturing high-performance liquid chromatography to diagnose cerebral autosomal dominant arteriopathy in Chinese patients with subcortical infarcts and leukoencephalopathy

Denaturing high-performance liquid chromatography to diagnose cerebral autosomal dominant arteriopathy in Chinese patients with subcortical infarcts and leukoencephalopathy
暂未订购
导出
摘要 BACKGROUND: Notch3 mutations are the molecular genetic foundation for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Of all currently available detection methods, direct sequencing or restriction enzymes are frequently used, but the cost is relatively high, because the Notch3 gene is composed of many exons and mutational sites are widely distributed. Denaturing high-performance liquid chromatography (DHPLC) exhibits high efficiency and specificity and has been applied to gene detection. To date, there has no report regarding DHPLC in gene detection of large-scale CADASIL families in China. OBJECTIVE: To explore the application and value of DHPLC in the diagnosis of CADASIL by a mutation screening for Notch3 gene in CADASIL probands and their family members. DESIGN, TIME AND SETTING: A comparative observation was performed at the Genetic Diagnosis Laboratory of Institute of Geriatrics, Xuanwu Hospital of Capital Medical University and the Key Laboratory for Neurodegenerative Disease of the Ministry of Education between August 2003 and May 2004. PARTICIPANTS: Fourteen CADASIL patients and their family members, comprising eight males and six females, aged 38-62 years, were included. Their key features included recurrent sub-cortical ischemic events and vascular dementia. In addition, 100 healthy physical examinees were selected as controls, including 52 males and 48 females, aged 56-72 years, who had no neurodegenerative disease or psychosis, and no history or high risk for cerebrovascular disease. METHODS: DNA was extracted from white blood cells. Ten hotspots of the Notch3 gene for sequence variation were first amplified by PCR, and the products were detected using DHPLC, Exons exhibiting a variant in the DHPLC profile underwent another PCR amplification, followed by DNA sequencing to identify the mutation type, In addition, patients with normal DHPLC peak profiles underwent PCR amplification for the remaining 13 exons, DNA sequencing was performed for the exons, exhibiting a variation in the DHPLC profile to identify the mutation type. At the same time, Notch3 gene detection was undertaken in 100 healthy controls. MAIN OUTCOME MEASURES: Peak profile changes of PCR products under different column temperatures during DHPLC detection; Notch3 pathogenic mutations and polymorphisms. RESULTS: Three heterozygous missense mutations at exon3 and exon4, as well as 15 polymorphisms, were detected in DHPLC patients and their family members. Of the three heterozygous missense mutations, Cys134Tyr, a novel mutation, had not been previously reported in China. None of these mutations was found in 200 chromosomes of the controls, In addition, DHPLC did not exhibit noticeable changes after a 1 ℃ temperature adjustment, while 3℃ was too great and might result in DNA melting and indiscernible peak profile, so 2℃ was determined to be appropriate, CONCLUSION: DHPLC technique exhibits efficiency, sensitivity, and specificity in screening for Notch3 gene mutations, The optimal column temperature allows for two degrees of fluctuation based on the temperature recommended by applied software and peak alterations during screening. BACKGROUND: Notch3 mutations are the molecular genetic foundation for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Of all currently available detection methods, direct sequencing or restriction enzymes are frequently used, but the cost is relatively high, because the Notch3 gene is composed of many exons and mutational sites are widely distributed. Denaturing high-performance liquid chromatography (DHPLC) exhibits high efficiency and specificity and has been applied to gene detection. To date, there has no report regarding DHPLC in gene detection of large-scale CADASIL families in China. OBJECTIVE: To explore the application and value of DHPLC in the diagnosis of CADASIL by a mutation screening for Notch3 gene in CADASIL probands and their family members. DESIGN, TIME AND SETTING: A comparative observation was performed at the Genetic Diagnosis Laboratory of Institute of Geriatrics, Xuanwu Hospital of Capital Medical University and the Key Laboratory for Neurodegenerative Disease of the Ministry of Education between August 2003 and May 2004. PARTICIPANTS: Fourteen CADASIL patients and their family members, comprising eight males and six females, aged 38-62 years, were included. Their key features included recurrent sub-cortical ischemic events and vascular dementia. In addition, 100 healthy physical examinees were selected as controls, including 52 males and 48 females, aged 56-72 years, who had no neurodegenerative disease or psychosis, and no history or high risk for cerebrovascular disease. METHODS: DNA was extracted from white blood cells. Ten hotspots of the Notch3 gene for sequence variation were first amplified by PCR, and the products were detected using DHPLC, Exons exhibiting a variant in the DHPLC profile underwent another PCR amplification, followed by DNA sequencing to identify the mutation type, In addition, patients with normal DHPLC peak profiles underwent PCR amplification for the remaining 13 exons, DNA sequencing was performed for the exons, exhibiting a variation in the DHPLC profile to identify the mutation type. At the same time, Notch3 gene detection was undertaken in 100 healthy controls. MAIN OUTCOME MEASURES: Peak profile changes of PCR products under different column temperatures during DHPLC detection; Notch3 pathogenic mutations and polymorphisms. RESULTS: Three heterozygous missense mutations at exon3 and exon4, as well as 15 polymorphisms, were detected in DHPLC patients and their family members. Of the three heterozygous missense mutations, Cys134Tyr, a novel mutation, had not been previously reported in China. None of these mutations was found in 200 chromosomes of the controls, In addition, DHPLC did not exhibit noticeable changes after a 1 ℃ temperature adjustment, while 3℃ was too great and might result in DNA melting and indiscernible peak profile, so 2℃ was determined to be appropriate, CONCLUSION: DHPLC technique exhibits efficiency, sensitivity, and specificity in screening for Notch3 gene mutations, The optimal column temperature allows for two degrees of fluctuation based on the temperature recommended by applied software and peak alterations during screening.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2008年第6期674-678,共5页 中国神经再生研究(英文版)
基金 the National High-Tech Research and Development Program of China (863 Program), No. 2001AA227051
关键词 CADASIL DHPLC Notch3 mutation CADASIL DHPLC Notch3 mutation
  • 相关文献

参考文献3

二级参考文献39

  • 1张清炯,箕田健生,曾瑞萍,吴中耀.10例遗传型视网膜母细胞瘤肿瘤组织Rb基因突变分析[J].中华眼底病杂志,1997,13(1):17-17. 被引量:1
  • 2张清炯,箕田健生,曾瑞萍.简便基因诊断在视网膜母细胞瘤风险预测的临床应用[J].中国实用眼科杂志,1997,15(5):272-274. 被引量:2
  • 3Kotaka M, Gover S, Vandeputte-Rutten L, et al. Structural studies of glucose-6- phosphate and NADP ( + ) binding to human glucose-6-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr,2005, 61 (Pt 5):495-504.
  • 4Du CS, Ren X, Chen L, et al. Detection the most common G6PD gene mutation in Chinese using amplication refractory mutation system. Hum Hered, 1999,49:133-138.
  • 5Zhao F, Ou XL, Xu CC, et al. Rapid detection of six common Chinese G6PD mutations by MALDI-TOF MS. Blood Cells Mol Dis, 2004,32:315-318.
  • 6Wu G, Hang WH, Zhu J, et al. Simultaneous genotyping of 10 Southeast Asian glucose-6-phosphate dehydrogenase deficiency-causing mutations and a silent polymorphism by multiplex primer extension/denaturing HPLCmethod. Clin Chem ,2005,51:1288-1291.
  • 7Du CS, Xu YK, Hu XY. Favism. 1st ed, Beijing, People's Medical Publish House, 1987.189-192.
  • 8Xiao WZ, Oefner PJ. Denaturing high-performance liquid chromatography:a review human mutation. Hum Mutat, 2001,17:439-474.
  • 9Golstein DB, Hiscohom JN. In genetic control of disease, does "race" matter. Nat Gene,2004;36:1243-1244.
  • 10Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurology, 2003,2:731-740.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部